1
|
Spasov A, Ozerov A, Vassiliev P, Kosolapov V, Gurova N, Kucheryavenko A, Naumenko L, Babkov D, Sirotenko V, Taran A, Litvinov R, Borisov A, Klochkov V, Merezhkina D, Miroshnikov M, Uskov G, Ovsyankina N. Synthesis and multifaceted pharmacological activity of novel quinazoline NHE-1 inhibitors. Sci Rep 2021; 11:24380. [PMID: 34934125 PMCID: PMC8692498 DOI: 10.1038/s41598-021-03722-w] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2021] [Accepted: 12/09/2021] [Indexed: 11/20/2022] Open
Abstract
The Na+/H+ exchanger isoform 1 (NHE-1) attracts ongoing attention as a validated drug target for the management of cardiovascular and ocular diseases owing to cytoprotective, anti-ischemic and anti-inflammatory properties of NHE-1 inhibitors. Herein we report novel NHE-1 inhibitors realized via functionalization of N1-alkyl quinazoline-2,4(1H,3H)-dione and quinazoline-4(3H)-one with N-acylguanidine or 3-acyl(5-amino-1,2,4-triazole) side chain. Lead compounds show activity in a nanomolar range. Their pharmacophoric features were elucidated with neural network modeling. Several compounds combine NHE-1 inhibition with antiplatelet activity. Compound 6b reduces intraocular pressure in rats and effectively inhibits the formation of glycated proteins. Compounds 3e and 3i inhibit pro-inflammatory activation of murine macrophages, LPS-induced interleukin-6 secretion and also exhibit antidepressant activity similar to amiloride. Hence, novel compounds represent an interesting starting point for the development of agents against cardiovascular diseases, thrombotic events, excessive inflammation, long-term diabetic complications and glaucoma.
Collapse
Affiliation(s)
- Alexander Spasov
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131 ,grid.445050.00000 0000 8790 3085Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia 400087
| | - Alexander Ozerov
- grid.445050.00000 0000 8790 3085Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia 400087 ,grid.445050.00000 0000 8790 3085Department of Pharmaceutical & Toxicological Chemistry, Volgograd State Medical University, Volgograd, Russia 400131
| | - Pavel Vassiliev
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131 ,grid.445050.00000 0000 8790 3085Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia 400087
| | - Vadim Kosolapov
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131 ,grid.445050.00000 0000 8790 3085Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia 400087
| | - Natalia Gurova
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131 ,grid.445050.00000 0000 8790 3085Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia 400087
| | - Aida Kucheryavenko
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131
| | - Ludmila Naumenko
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131
| | - Denis Babkov
- Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia, 400131. .,Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia, 400087.
| | - Viktor Sirotenko
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131 ,grid.445050.00000 0000 8790 3085Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia 400087
| | - Alena Taran
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131 ,grid.445050.00000 0000 8790 3085Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia 400087
| | - Roman Litvinov
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131 ,grid.445050.00000 0000 8790 3085Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia 400087
| | - Alexander Borisov
- grid.445050.00000 0000 8790 3085Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia 400087
| | - Vladlen Klochkov
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131
| | - Darya Merezhkina
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131
| | - Mikhail Miroshnikov
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131 ,grid.445050.00000 0000 8790 3085Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia 400087
| | - Georgy Uskov
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131
| | - Nadezhda Ovsyankina
- grid.445050.00000 0000 8790 3085Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia 400131
| |
Collapse
|
3
|
Sowmiah S, Esperança JMSS, Rebelo LPN, Afonso CAM. Pyridinium salts: from synthesis to reactivity and applications. Org Chem Front 2018. [DOI: 10.1039/c7qo00836h] [Citation(s) in RCA: 157] [Impact Index Per Article: 26.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
This review highlights the pyridinium salts in terms of their natural occurrence, synthesis, reactivity, biological properties, and diverse applications.
Collapse
Affiliation(s)
- Subbiah Sowmiah
- Instituto de Tecnologia Química e Biológica António Xavier
- Universidade Nova de Lisboa
- 2780-157 Oeiras
- Portugal
- Research Institute for Medicines (iMed.ULisboa)
| | - José M. S. S. Esperança
- Instituto de Tecnologia Química e Biológica António Xavier
- Universidade Nova de Lisboa
- 2780-157 Oeiras
- Portugal
- LAQV-REQUIMTE
| | - Luís P. N. Rebelo
- Instituto de Tecnologia Química e Biológica António Xavier
- Universidade Nova de Lisboa
- 2780-157 Oeiras
- Portugal
- LAQV-REQUIMTE
| | - Carlos A. M. Afonso
- Research Institute for Medicines (iMed.ULisboa)
- Faculty of Pharmacy
- Universidade de Lisboa
- 1649-009 Lisboa
- Portugal
| |
Collapse
|